{"abstract":"The Drug Enforcement Administration proposes placing the substance tianeptine (7-[(3-chloro-6,11-dihydro-6-methyl-5,5- dioxidodibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, salts, and salts of isomers, esters, and ethers is possible, in schedule I of the Controlled Substances Act. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle tianeptine.","action":"Notice of proposed rulemaking.","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2026/07/08/2026-13821.html","cfr_references":[{"chapter":null,"citation_url":null,"part":"1308","title":21}],"citation":"91 FR 42150","comment_url":null,"comments_close_on":"2026-08-07","correction_of":null,"corrections":[],"dates":"Comments must be submitted electronically or postmarked on or before August 7, 2026. The electronic Federal Docket Management System will not accept comments after 11:59 p.m. Eastern Time on the last day of the comment period.","disposition_notes":null,"docket_ids":["Docket No. DEA1596"],"dockets":[{"supporting_documents":[{"title":"HHS 8FA Report Tianeptine _6-22-25","document_id":"DEA-2026-1091-0004"},{"title":"DEA Tianeptine 8 Factor July 2026","document_id":"DEA-2026-1091-0003"},{"title":"HHS Tianeptine Scheduling Recommendation dated 7-10-25","document_id":"DEA-2026-1091-0001"}],"agency_name":"DEA","documents":[{"comment_count":188,"comment_start_date":"2026-07-08","updated_at":"2026-08-08T01:56:26.383-04:00","comment_url":"https://www.regulations.gov/commenton/DEA-2026-1091-0002","allow_late_comments":false,"id":"DEA-2026-1091-0002","comment_end_date":"2026-08-08","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":3,"id":"DEA-2026-1091","title":"Schedules of Controlled Substances: Placement of Tianeptine in Schedule 1 (DEA1596)"}],"document_number":"2026-13821","effective_on":null,"end_page":42158,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2026/07/08/2026-13821.xml","html_url":"https://www.federalregister.gov/documents/2026/07/08/2026-13821/schedules-of-controlled-substances-placement-of-tianeptine-in-schedule-i","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2026-13821?publication_date=2026-07-08","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2026-07-08/2026-13821/mods.xml","not_received_for_publication":null,"page_length":9,"page_views":{"count":3685,"last_updated":"2026-09-21 20:15:12 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-07-08/pdf/2026-13821.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-13821.pdf?1783428319","publication_date":"2026-07-08","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2026/07/08/2026-13821.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[{"title":"HHS 8FA Report Tianeptine _6-22-25","document_id":"DEA-2026-1091-0004"},{"title":"DEA Tianeptine 8 Factor July 2026","document_id":"DEA-2026-1091-0003"},{"title":"HHS Tianeptine Scheduling Recommendation dated 7-10-25","document_id":"DEA-2026-1091-0001"}],"comments_count":188,"agency_id":"DEA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=DEA-2026-1091","supporting_documents_count":3,"docket_id":"DEA-2026-1091","document_id":"DEA-2026-1091-0002","regulation_id_number":null,"title":"Schedules of Controlled Substances: Placement of Tianeptine in Schedule 1 (DEA1596)","checked_regulationsdotgov_at":"2026-08-09T08:55:03Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":42150,"subtype":null,"title":"Schedules of Controlled Substances: Placement of Tianeptine in Schedule I","toc_doc":"Placement of Tianeptine in Schedule I","toc_subject":"Schedules of Controlled Substances","topics":["Administrative practice and procedure","Drug traffic control","Reporting and recordkeeping requirements"],"type":"Proposed Rule","volume":91}